Company profile: Nemera
1.1 - Company Overview
Company description
- Provider of design, development and manufacturing of drug delivery solutions for pharmaceutical, biotechnology and generics industries, covering parenteral, nasal, buccal, auricular, ophthalmic, pulmonary, dermal and transdermal modes of delivery.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nemera
Nurse Assist
HQ: United States
Website
- Description: Provider of medical devices and USP sterile solutions, including prefilled saline syringes for IV flushing, sterile water and normal saline for irrigation and respiratory care, and sterile saline wound flush for moistening, debriding, and cleaning wounds, helping reduce contamination, medication errors, and needlestick injuries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nurse Assist company profile →
Innocoll
HQ: United States
Website
- Description: Provider of targeted drug delivery solutions focused on biodegradable surgical implants and topically applied healthcare products, including XARACOLL, a resorbable collagen implant with bupivacaine for pain relief up to 24 hours after open inguinal hernia repair; POSIMIR, a single‑site bupivacaine injection providing relief up to 72 hours after arthroscopic subacromial decompression; the COLLARx collagen matrix platform; and CDMO services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Innocoll company profile →
PLx Pharma
HQ: United States
Website
- Description: Provider of non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets, developing and commercializing these therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PLx Pharma company profile →
Alexza
HQ: United States
Website
- Description: Provider of inhaled therapeutics for acute and intermittent conditions, featuring commercial ADASUVE (loxapine) for acute agitation in adults with schizophrenia or bipolar disorder, and developing Staccato inhalation candidates: alprazolam for epileptic seizures, apomorphine for OFF episodes in Parkinson’s disease, and granisetron for cyclic vomiting syndrome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alexza company profile →
Milestone Scientific
HQ: United States
Website
- Description: Provider of computer-controlled injection technologies for medical and dental care, including the CompuFlo Epidural Instrument with visual/audio feedback to locate the epidural space; the STA Single Tooth Anesthesia system for precise dental delivery; DPS Dynamic Pressure Sensing and automated flow/pressure control for consistent injections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Milestone Scientific company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nemera
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nemera
2.2 - Growth funds investing in similar companies to Nemera
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nemera
4.2 - Public trading comparable groups for Nemera
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →